M&A / Deals Eli Lilly to Acquire Kelonia Therapeutics Big Molecule WatchOn April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc.Read full story pharminent May 4, 2026 (Last updated: May 4, 2026) Big Molecule Watch On April 20, 2026, Eli Lilly Company ( Lilly ) and Kelonia Therapeutics, Inc. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Gene therapy’s evidence problem–lessons from recent FDA decisionsNext: 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease Related Stories M&A / Deals AbbVie climbs post-Allergan M&A peak with Apogee buy pharminent June 22, 2026 M&A / Deals Lilly bets up to $800M for BioArctic’s brain delivery tech pharminent June 22, 2026 M&A / Deals Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance pharminent June 22, 2026
